All Stories

  1. Durability of dolutegravir plus boosted darunavir as salvage or simplification of salvage regimens in HIV-1 infected, highly treatment-experienced subjects

    Article • HIV Clinical Trials, November 2018, Taylor & Francis

    Dr GAETANA STERRANTINO, Dr Giovanni Cenderello

  2. Continuum of care among HIV-1 positive patients in a single center in Italy (2007–2017)

    Article • Patient Preference and Adherence, November 2018, Dove Medical Press

    Dr GAETANA STERRANTINO, Seble Tekle Kiros

  3. Self-reported adherence supports patient preference for the single tablet regimen (STR) in the current cART era

    Article • Patient Preference and Adherence, June 2012, Taylor & Francis

    Dr GAETANA STERRANTINO